Milestone Scientific Schedules First Quarter 2016 Earnings Conference Call
Get Alerts MLSS Hot Sheet
Join SI Premium – FREE
LIVINGSTON, NJ -- (Marketwired) -- 05/16/16 -- Milestone Scientific Inc. (NYSE: MLSS), a medical R&D company that designs, patents, incubates and commercializes a growing portfolio of innovative injection technologies, today announced that it will host a conference call at 8:30 AM Eastern Time on Tuesday, May 17, 2016 to discuss the Company's financial results for the first quarter ended March 31, 2016, as well as the Company's corporate progress and other developments.
The conference call will be available via telephone by dialing toll free 888-631-5930 and entering the pass code 9556844 or on the company's website at www.milestonescientific.com. For those unable to participate at that time, a replay of the call will be archived on the company's website or can be accessed by dialing 888-203-1112 and entering the pass code 9556844. The replay will be available for 90 days.
About Milestone Scientific Inc.
Milestone Scientific Inc. (MLSS) is a leading medical research and development company that designs and patents innovative injection technology. Milestone's computer-controlled systems make injections precise, efficient, and virtually painless. For more information please visit our website: www.milestonescientific.com.
Contact:
David Waldman or Natalya RudmanCrescendo Communications, LLCEmail: [email protected]: 212-671-1020
Source: Milestone Scientific Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- GitLab’s second-quarter revenue jumps 21% as AI demand drives bookings
- Everus Construction Group acquires Epsilon Industries for $295M
- Ryman Hospitality closes $1.38B Grande Lakes Orlando deal
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share